These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 30303498)

  • 1. Synthesis, cytotoxic activity and DNA interaction studies of new dinuclear platinum(ii) complexes with an aromatic 1,5-naphthyridine bridging ligand: DNA binding mode of polynuclear platinum(ii) complexes in relation to the complex structure.
    Konovalov B; Živković MD; Milovanović JZ; Djordjević DB; Arsenijević AN; Vasić IR; Janjić GV; Franich A; Manojlović D; Skrivanj S; Milovanović MZ; Djuran MI; Rajković S
    Dalton Trans; 2018 Oct; 47(42):15091-15102. PubMed ID: 30303498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New minor groove covering DNA binding mode of dinuclear Pt(II) complexes with various pyridine-linked bridging ligands and dual anticancer-antiangiogenic activities.
    Franich AA; Živković MD; Ilić-Tomić T; Đorđević IS; Nikodinović-Runić J; Pavić A; Janjić GV; Rajković S
    J Biol Inorg Chem; 2020 May; 25(3):395-409. PubMed ID: 32162071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of series of diazine-bridged dinuclear platinum(II) complexes through in vitro toxicity and molecular modeling: correlation between structure and activity of Pt(II) complexes.
    Senerovic L; Zivkovic MD; Veselinovic A; Pavic A; Djuran MI; Rajkovic S; Nikodinovic-Runic J
    J Med Chem; 2015 Feb; 58(3):1442-51. PubMed ID: 25551180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivoactivity of series of cationic dinuclearPt(II) complexes.
    Vasić I; Rajković S; Arsenijević A; Milovanović M; Arsenijević N; Milovanović J; Živković MD
    J Inorg Biochem; 2021 Dec; 225():111619. PubMed ID: 34597886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic activity and influence on acetylcholinesterase of series dinuclear platinum(II) complexes with aromatic nitrogen-containing heterocyclic bridging ligands: Insights in the mechanisms of action.
    Bondžić AM; Žakula JJ; Korićanac LB; Keta OD; Janjić GV; Đorđević IS; Rajković SU
    Chem Biol Interact; 2022 Jan; 351():109708. PubMed ID: 34666020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strong in vitro and vivo cytotoxicity of novel organoplatinum(II) complexes with quinoline-coumarin derivatives.
    Qin QP; Wang ZF; Huang XL; Tan MX; Zou BQ; Liang H
    Eur J Med Chem; 2019 Dec; 184():111751. PubMed ID: 31593828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo anti-tumor effects of selected platinum(IV) and dinuclear platinum(II) complexes against lung cancer cells.
    Arsenijevic M; Milovanovic M; Jovanovic S; Arsenijevic N; Markovic BS; Gazdic M; Volarevic V
    J Biol Inorg Chem; 2017 Aug; 22(6):807-817. PubMed ID: 28421385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dinuclear Platinum(II) Complexes with Bone-Targeting Groups as Potential Anti-Osteosarcoma Agents.
    Zhang Z; Wang X; Luo C; Zhu C; Wang K; Zhang C; Guo Z
    Chem Asian J; 2017 Jul; 12(13):1659-1667. PubMed ID: 28556606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization, modes of interactions with DNA/BSA biomolecules and anti-tumor activity of newly synthesized dinuclear platinum(II) complexes with pyridazine bridging ligand.
    Zornić S; Simović Marković B; Franich AA; Janjić GV; Jadranin MB; Avdalović J; Rajković S; Živković MD; Arsenijević NN; Radosavljević GD; Pantić J
    J Biol Inorg Chem; 2024 Feb; 29(1):51-73. PubMed ID: 38099936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syntheses, crystal structures, and biological evaluations of new dinuclear platinum(ii) complexes with 1,2,4-triazole derivatives as bridging ligands.
    Wang J; Li X; Yuan C; Su F; Wu YB; Lu L; Zhu M; Xing S; Fu X
    Dalton Trans; 2021 Apr; 50(13):4527-4538. PubMed ID: 33725030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three Pt-Pt Complexes with Donor-acceptor Feature: Anticancer Activity, DNA Binding Studies and Molecular Docking Simulation.
    Ashoo P; Yousefi R; Nabavizadeh SM; Aseman MD; Paziresh S; Ghasemi A; Saboury AA
    Anticancer Agents Med Chem; 2019; 19(14):1762-1774. PubMed ID: 31267879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
    Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
    J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, characterization and cytotoxic activity of novel platinum(II) iodido complexes.
    Savić A; Filipović L; Aranđelović S; Dojčinović B; Radulović S; Sabo TJ; Grgurić-Šipka S
    Eur J Med Chem; 2014 Jul; 82():372-84. PubMed ID: 24927057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monofunctional platinum(II) complexes with potent tumor cell growth inhibitory activity: the effect of a hydrogen-bond donor/acceptor N-heterocyclic ligand.
    Margiotta N; Savino S; Gandin V; Marzano C; Natile G
    ChemMedChem; 2014 Jun; 9(6):1161-8. PubMed ID: 24799414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro cytotoxic activities, DNA- and BSA-binding studies of dinuclear palladium(II) complexes with different pyridine-based bridging ligands.
    Franich AA; Živković MD; Milovanović J; Arsenijević D; Arsenijević A; Milovanović M; Djuran MI; Rajković S
    J Inorg Biochem; 2020 Sep; 210():111158. PubMed ID: 32622215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. trans-Dichloridopalladium(II) and platinum(II) complexes with 2-(hydroxymethyl)pyridine and 2-(2-hydroxyethyl)pyridine: synthesis, structural characterization, DNA binding and in vitro cytotoxicity studies.
    Icsel C; Yilmaz VT; Ari F; Ulukaya E; Harrison WT
    Eur J Med Chem; 2013 Feb; 60():386-94. PubMed ID: 23314052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dinuclear platinum(II) complexes of imidazophenanthroline-based bridging ligands as potential anticancer agents: synthesis, characterization, and in vitro cytotoxicity studies.
    Alexander C; Prajith NU; Priyanka PV; Nithyakumar A; Arockia Samy N
    J Biol Inorg Chem; 2019 May; 24(3):405-418. PubMed ID: 30945024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, characterization, interaction with DNA, and cytotoxic effect in vitro of new mono- and dinuclear Pd(II) and Pt(II) complexes with benzo[d]thiazol-2-amine as the primary ligand.
    Gao E; Liu L; Zhu M; Huang Y; Guan F; Gao X; Zhang M; Wang L; Zhang W; Sun Y
    Inorg Chem; 2011 Jun; 50(11):4732-41. PubMed ID: 21520903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel tacrine platinum(II) complexes display high anticancer activity via inhibition of telomerase activity, dysfunction of mitochondria, and activation of the p53 signaling pathway.
    Qin QP; Wang SL; Tan MX; Wang ZF; Luo DM; Zou BQ; Liu YC; Yao PF; Liang H
    Eur J Med Chem; 2018 Oct; 158():106-122. PubMed ID: 30205260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of platinum(II) and (IV) complexes of 1,3-diaminepropane and 1,4-diaminebutane: circumvention of cisplatin resistance and DNA interstrand cross-link formation in CH1cisR ovarian tumor cells.
    Alvarez-Valdés A; Pérez JM; López-Solera I; Lannegrand R; Continente JM; Amo-Ochoa P; Camazón MJ; Solans X; Font-Bardía M; Navarro-Ranninger C
    J Med Chem; 2002 Apr; 45(9):1835-44. PubMed ID: 11960495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.